Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nick, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Program Officer \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Lubman, David M.	University Of Michigan At Ann Arbor United States	Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach	5R01CA160254-14	Matthew Young, Ph.D.
Lyden, David Charles	Weill Medical Coll Of Cornell Univ United States	Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection	5R01CA218513-08	Matthew Young, Ph.D.
Maitra, Anirban	New York University School Of Medicine United States	Clinical Validation Center for Early Detection of Pancreatic Cancer	7U01CA200468-09	Matthew Young, Ph.D.
Majumder, Shounak	Mayo Clinic Rochester United States	Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer	5U01CA210138-09	Matthew Young, Ph.D.
Maldonado, Fabien	Vanderbilt University Medical Center United States	Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures	5R01CA253923-05
Mallick, Parag Kumar	Stanford University United States	Pathomic Predictors of Prostate Cancer Progression	5R01CA249899-05
Marchetti, Dario	University Of New Mexico Health Scis Ctr United States	Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF	5R01CA216991-07	Matthew Young, Ph.D.
Markowitz, Sanford D.	Case Western Reserve University United States	Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation	5U01CA271867-04	Matthew Young, Ph.D.
Martinez-Conde, Susana	Suny Downstate Medical Center United States	Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance	5R01CA258021-05	Guillermo Marquez, Ph.D.
Mello-Thoms, Claudia R	University Of Iowa United States	Satisfaction of Search in Breast Cancer Detection	5R01CA259048-05
Metzger, Gregory John	University Of Minnesota United States	Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI	4R01CA241159-05	Guillermo Marquez, Ph.D.
Nappi, Lucia	Provincial Health Services Authority United States	Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration.	5R37CA264798-03	Guillermo Marquez, Ph.D.
Nath, Kavindra	University Of Pennsylvania United States	Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition	5R01CA228457-05
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-04	Guillermo Marquez, Ph.D.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02	Guillermo Marquez, Ph.D.